Belfast, Northern Ireland, United Kingdom Clarendon Fund Managers is the famous VC, which was founded in 2001. The main department of described VC is located in the Belfast. The venture was found in Europe in United Kingdom.
The fund has exact preference in a number of founders of portfolio startups. Among the most successful fund investment fields, there are Software, Medical Device. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United Kingdom. Among the most popular portfolio startups of the fund, we may highlight Datactics, axial3D, Kelsius. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Comparing to the other companies, this Clarendon Fund Managers performs on 16 percentage points less the average number of lead investments. The important activity for fund was in 2019. When the investment is from Clarendon Fund Managers the average startup value is 1-5 millions dollars. The fund is generally included in less than 2 deals every year. Deals in the range of 1 - 5 millions dollars are the general things for fund. Speaking about the real fund results, this VC is 8 percentage points less often commits exit comparing to other organizations. The top amount of exits for fund were in 2010.
Besides them, we counted 5 critical employees of this fund in our database.
The usual cause for the fund is to invest in rounds with 2-3 partakers. Despite the Clarendon Fund Managers, startups are often financed by Techstart Ventures, Pitch@Palace, Crescent Capital. The meaningful sponsors for the fund in investment in the same round are Techstart Ventures, QUBIS, Crescent Capital. In the next rounds fund is usually obtained by Kernel Capital, Invest Northern Ireland, Siemens Technology Accelerator.
Related Funds
Funds with similar focus
| Fund Name | Location |
| Adamant Biomedical Investments AG | Switzerland, Zürich, Zurich |
| Cathay Life Insurance | Taipei, Taiwan |
| China Jianteng Sports Industry Fund | - |
| Esas Ventures | Istanbul, Istanbul, Turkey |
| Hankyu Hanshin | Japan, Osaka, Osaka Prefecture |
| Hong Kong X Foundation | China, Hong Kong, Kowloon |
| IDC Frontier | Japan, Tokyo |
| M&S Partners | Calebasses, Mauritius, Pamplemousses |
| Myca Partners | New York, New York, United States |
| New Brunswick Investment Management Corporation | Canada, Fredericton, Nova Scotia |
| ReBeage | Japan, Setagaya |
| Redcrest Enterprises | - |
| Sawada Holdings | Japan, Shinjuku |
| Seerave Foundation | - |
| Turbo Capital | Beijing, Beijing, China |
| United States Army | Arlington, United States, Virginia |
| Valent Group | California, San Francisco, United States |
| Vess Capital | - |
| Zhejiang Lizi Venture Capital | China, Hangzhou, Zhejiang |
Discover 4 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Needi | 24 Oct 2024 | Manchester, Greater Manchester, United Kingdom | |||
INQDATA | $1M | 24 Jul 2024 | Belfast, Northern Ireland, United Kingdom | ||
Sapien Health | $2M | 15 Nov 2022 | London, England, United Kingdom | ||
Angoka | $3M | 08 Nov 2022 | Belfast, Northern Ireland, United Kingdom | ||
Rock Extraction | $654K | 27 Sep 2022 | Antrim, Northern Ireland, United Kingdom | ||
RETìníZE | $2M | 16 Mar 2022 | Belfast, Northern Ireland, United Kingdom | ||
Datactics | $2M | 05 May 2021 | Belfast, Northern Ireland, United Kingdom | ||
B-Secur | $2M | 15 Sep 2020 | Belfast, Northern Ireland, United Kingdom | ||
Neurovalens | $6M | 20 Jul 2020 | Belfast, Northern Ireland, United Kingdom |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Needi | 24 Oct 2024 | Manchester, Greater Manchester, United Kingdom | |||
INQDATA | $1M | 24 Jul 2024 | Belfast, Northern Ireland, United Kingdom | ||
Sapien Health | $2M | 15 Nov 2022 | London, England, United Kingdom | ||
Angoka | $3M | 08 Nov 2022 | Belfast, Northern Ireland, United Kingdom | ||
Rock Extraction | $654K | 27 Sep 2022 | Antrim, Northern Ireland, United Kingdom | ||
RETìníZE | $2M | 16 Mar 2022 | Belfast, Northern Ireland, United Kingdom | ||
Datactics | $2M | 05 May 2021 | Belfast, Northern Ireland, United Kingdom | ||
B-Secur | $2M | 15 Sep 2020 | Belfast, Northern Ireland, United Kingdom | ||
Neurovalens | $6M | 20 Jul 2020 | Belfast, Northern Ireland, United Kingdom |
